Related Experiment Video
Updated: Jun 8, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Enfuvirtide administration in HIV-positive transgender patient with soft tissue augmentation: US evaluation
Eugenia Gabrielli1, Giovanna Ferraioli, Laurenzia Ferraris
1Clinical Science Department, Section of Infectious Diseases, University of Milan, L. Sacco Hospital, Milan, Italy.
Abstract:
Enfuvirtide is a large protein that should be injected subcutaneously to ensure an appropriate absorption. Here we report the case of a transgender HIV-positive patient receiving enfuvirtide with an individualized background regimen of antiretroviral drugs, who had previously undergone liquid silicone oil injections. We performed US scan to detect silicone-free areas for following enfuvirtide injections. US can be useful in the correct management of those patients with liquid silicone oil soft tissue augmentation who require subcutaneously injected drugs.
Related Concept Videos
Sexually Transmitted Infections
Retroviruses
Subviral Agents
Antiviral Nucleoside Inhibitors
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Transdermal Drug Delivery Systems

